Heath D A, Van't Hoff W, Barnes A D, Gray J G
Br Med J. 1979 Feb 17;1(6161):450-2. doi: 10.1136/bmj.1.6161.450.
The postoperative course of six patients with primary hyperparathyroidism and obvious radiological evidence of bone disease pretreated with 1-alpha-hydroxy vitamin D3 (1 alpha HCC) was indistinguishable from that of six patients with a similar clinical and radiological picture who were not pretreated. 1alphaHCC may increase the hypercalcaemia in some cases and cannot be recommended for the routine preparation of such patients for surgery.
6例原发性甲状旁腺功能亢进且有明显骨病放射学证据的患者,术前用1α-羟基维生素D3(1αHCC)预处理,其术后病程与6例有相似临床和放射学表现但未接受预处理的患者并无差异。1αHCC在某些情况下可能会加重高钙血症,因此不建议将其用于此类患者手术的常规术前准备。